Schneck SA - Search Results

1

Transplantation of human fetal dopamine cells for Parkinson's disease. Results at 1 year.

Freed CR, Breeze RE, Rosenberg NL, Schneck SA, Wells TH, Barrett JN, Grafton ST, Huang SC, Eidelberg D, Rottenberg DA. Freed CR, et al. Among authors: schneck sa. Arch Neurol. 1990 May;47(5):505-12. doi: 10.1001/archneur.1990.00530050021007. Arch Neurol. 1990. PMID: 2334298

2

Improved drug responsiveness following fetal tissue implant for Parkinson's disease.

Freed CR, Rosenberg NL, Schneck SA, Breeze RE. Freed CR, et al. Among authors: schneck sa. Neurochem Int. 1992 Mar;20 Suppl:321S-327S. doi: 10.1016/0197-0186(92)90259-t. Neurochem Int. 1992. PMID: 1365449 No abstract available.

3

Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease.

Freed CR, Breeze RE, Rosenberg NL, Schneck SA, Kriek E, Qi JX, Lone T, Zhang YB, Snyder JA, Wells TH, et al. Freed CR, et al. Among authors: schneck sa. N Engl J Med. 1992 Nov 26;327(22):1549-55. doi: 10.1056/NEJM199211263272202. N Engl J Med. 1992. PMID: 1435881 Free article. Clinical Trial.

4

Therapeutic effects of human fetal dopamine cells transplanted in a patient with Parkinson's disease.

Freed CR, Breeze RE, Rosenberg NL, Schneck SA, Wells TH, Barrett JN, Grafton ST, Mazziotta JC, Eidelberg D, Rottenberg DA. Freed CR, et al. Among authors: schneck sa. Prog Brain Res. 1990;82:715-21. doi: 10.1016/s0079-6123(08)62664-3. Prog Brain Res. 1990. PMID: 2290975 No abstract available.

5

Embryonic dopamine cell implants as a treatment for the second phase of Parkinson's disease. Replacing failed nerve terminals.

Freed CR, Breeze RE, Rosenberg NL, Schneck SA. Freed CR, et al. Among authors: schneck sa. Adv Neurol. 1993;60:721-8. Adv Neurol. 1993. PMID: 8420217 No abstract available.

6

Transplantation of fetal mesencephalic tissue in Parkinson's disease.

Freed CR, Breeze RE, Schneck SA. Freed CR, et al. Among authors: schneck sa. N Engl J Med. 1995 Sep 14;333(11):730-1. doi: 10.1056/NEJM199509143331112. N Engl J Med. 1995. PMID: 7637761 No abstract available.

7

Lack of a detectable systemic humoral/cellular allogeneic response in human and nonhuman primate recipients of embryonic mesencephalic allografts for the therapy of Parkinson's disease.

Ansari AA, Mayne A, Freed CR, Breeze RE, Schneck SA, O'Brien CF, Kriek EH, Zhang YB, Mazziotta JC, Hutchinson M, et al. Ansari AA, et al. Among authors: schneck sa. Transplant Proc. 1995 Feb;27(1):1401-5. Transplant Proc. 1995. PMID: 7878926 Clinical Trial. No abstract available.

8

Diffuse Lewy body disease and progressive dementia.

Burkhardt CR, Filley CM, Kleinschmidt-DeMasters BK, de la Monte S, Norenberg MD, Schneck SA. Burkhardt CR, et al. Among authors: schneck sa. Neurology. 1988 Oct;38(10):1520-8. doi: 10.1212/wnl.38.10.1520. Neurology. 1988. PMID: 2843793 Review.

9

Syphilitic meningomyelitis.

Strom T, Schneck SA. Strom T, et al. Among authors: schneck sa. Neurology. 1991 Feb;41(2 ( Pt 1)):325-6. doi: 10.1212/wnl.41.2_part_1.325. Neurology. 1991. PMID: 1812840

10

Zoster sine herpete, a clinical variant.

Gilden DH, Wright RR, Schneck SA, Gwaltney JM Jr, Mahalingam R. Gilden DH, et al. Among authors: schneck sa. Ann Neurol. 1994 May;35(5):530-3. doi: 10.1002/ana.410350505. Ann Neurol. 1994. PMID: 8179298 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters